INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis
NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to INFU. INFU was compared to 102 industry peers in the Health Care Providers & Services industry. While INFU has a great profitability rating, there are some minor concerns on its financial health. INFU is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make INFU suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year INFU was profitable.
INFU had a positive operating cash flow in the past year.
Each year in the past 5 years INFU has been profitable.
Each year in the past 5 years INFU had a positive operating cash flow.
1.2 Ratios
The Return On Assets of INFU (3.06%) is better than 64.71% of its industry peers.
INFU has a Return On Equity of 5.78%. This is in the better half of the industry: INFU outperforms 62.75% of its industry peers.
INFU has a Return On Invested Capital of 7.47%. This is in the better half of the industry: INFU outperforms 72.55% of its industry peers.
INFU had an Average Return On Invested Capital over the past 3 years of 3.86%. This is significantly below the industry average of 9.62%.
The last Return On Invested Capital (7.47%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROIC | 7.47% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
INFU's Profit Margin of 2.32% is fine compared to the rest of the industry. INFU outperforms 62.75% of its industry peers.
INFU's Profit Margin has been stable in the last couple of years.
The Operating Margin of INFU (6.07%) is better than 63.73% of its industry peers.
INFU's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 53.13%, INFU is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
INFU's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
INFU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
INFU has more shares outstanding than it did 1 year ago.
The number of shares outstanding for INFU has been increased compared to 5 years ago.
Compared to 1 year ago, INFU has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.52 indicates that INFU is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.52, INFU is in line with its industry, outperforming 55.88% of the companies in the same industry.
The Debt to FCF ratio of INFU is 12.54, which is on the high side as it means it would take INFU, 12.54 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of INFU (12.54) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.52 indicates that INFU is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, INFU is in the better half of the industry, outperforming 60.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Altman-Z | 2.52 |
ROIC/WACC0.88
WACC8.46%
2.3 Liquidity
INFU has a Current Ratio of 2.21. This indicates that INFU is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of INFU (2.21) is better than 77.45% of its industry peers.
INFU has a Quick Ratio of 1.83. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
INFU has a Quick ratio of 1.83. This is in the better half of the industry: INFU outperforms 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 6900.00% over the past year.
INFU shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.59% yearly.
Looking at the last year, INFU shows a small growth in Revenue. The Revenue has grown by 7.98% in the last year.
INFU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.70% yearly.
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
3.2 Future
The Earnings Per Share is expected to grow by 84.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.03% on average over the next years. This is quite good.
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 42.93, the valuation of INFU can be described as expensive.
INFU's Price/Earnings is on the same level as the industry average.
INFU is valuated expensively when we compare the Price/Earnings ratio to 26.53, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 17.61, the valuation of INFU can be described as rather expensive.
INFU's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INFU is cheaper than 66.67% of the companies in the same industry.
INFU's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.93 | ||
| Fwd PE | 17.61 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INFU is valued cheaper than 83.33% of the companies in the same industry.
INFU's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.09 | ||
| EV/EBITDA | 7.15 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INFU may justify a higher PE ratio.
INFU's earnings are expected to grow with 84.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)4.06
EPS Next 2Y84.76%
EPS Next 3YN/A
5. Dividend
5.1 Amount
INFU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSEARCA:INFU (6/10/2025, 11:25:17 AM)
6.01
+0.06 (+1.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.82%
Inst Owner Change-0.34%
Ins Owners3.62%
Ins Owner Change0.69%
Market Cap126.09M
Analysts84
Price Target13.9 (131.28%)
Short Float %2.04%
Short Ratio2.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-48.06%
Max EPS beat(2)75.49%
EPS beat(4)2
Avg EPS beat(4)7.91%
Min EPS beat(4)-48.06%
Max EPS beat(4)75.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-4.92%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)6
Avg Revenue beat(12)-0.71%
Revenue beat(16)7
Avg Revenue beat(16)-1.97%
PT rev (1m)-3.54%
PT rev (3m)-3.54%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)-20.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-35.4%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.93 | ||
| Fwd PE | 17.61 | ||
| P/S | 0.92 | ||
| P/FCF | 55.09 | ||
| P/OCF | 5.77 | ||
| P/B | 2.29 | ||
| P/tB | 2.79 | ||
| EV/EBITDA | 7.15 |
EPS(TTM)0.14
EY2.33%
EPS(NY)0.34
Fwd EY5.68%
FCF(TTM)0.11
FCFY1.82%
OCF(TTM)1.04
OCFY17.34%
SpS6.56
BVpS2.63
TBVpS2.16
PEG (NY)0.54
PEG (5Y)4.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROCE | 9.46% | ||
| ROIC | 7.47% | ||
| ROICexc | 7.6% | ||
| ROICexgc | 8.58% | ||
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% | ||
| FCFM | 1.66% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Debt/EBITDA | 1.35 | ||
| Cap/Depr | 151.51% | ||
| Cap/Sales | 14.23% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.77% | ||
| Profit Quality | 71.76% | ||
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.52 |
F-Score9
WACC8.46%
ROIC/WACC0.88
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y149.37%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year297.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.23%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y64.52%
OCF growth 3Y3.76%
OCF growth 5Y8.08%